Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-22, Stock:PFE, The news for the past five days is as follows:
2019-01-14: NEWS1: Democrats target drug prices.NEWS2: Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe.NEWS3: Stocks slip as corporate earnings season begins.NEWS4: This Biotech Stock Plunged On Its Looming Rivalry With Pfizer.NEWS5: What Caused Exact Sciences Shares to Fall 19.1% in December.NEWS6: What Caused Exact Sciences Shares to Fall 19.1% in December.NEWS7: House Dems announce sweeping investigation of drug pricing.NEWS8: House Dems announce sweeping investigation of drug pricing.NEWS9: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS10: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS11: House Democrats launch drug pricing probe into a dozen major health-care companies.NEWS12: Sell Amarin Stock on the Recent Takeover Rumors Rally.NEWS13: Why Dow Jones' Pfizer Is Prepped To Rival These 2 Biotech Stocks.NEWS14: How To Approach Q4 Earnings: The Global Perspective.NEWS15: Modern Value Investing: Adding to the Value Investing Toolbox.NEWS16: Pfizer's new drug applications for tafamidis accepted for filing by FDA.NEWS17: Pfizer&apos;s new drug applications for tafamidis accepted for filing by FDA.NEWS18: US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy.NEWS19: Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis.NEWS20: Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis.NEWS21: Here Are the 2019 Dogs of the Dow.NEWS22: Here Are the 2019 Dogs of the Dow.NEWS23: Here Are the 2019 Dogs of the Dow.
2019-01-15: NEWS1: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS2: XLV, PFE, UNH, MRK: Large Inflows Detected at ETF.NEWS3: XLV, PFE, UNH, MRK: Large Inflows Detected at ETF.NEWS4: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS5: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS6: Pfizer Gets FDA's Priority Review for Rare Disease Candidate.NEWS7: Pfizer Gets FDA's Priority Review for Rare Disease Candidate.NEWS8: Health Care Sector Update for 01/15/2019: BPTH, ALNY, TRXC, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 01/15/2019: BPTH, ALNY, TRXC, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS11: Why Amarin Is Soaring in First Half of January.NEWS12: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS13: Pfizer Gets FDA's Priority Review for Rare Disease Candidate.NEWS14: Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019.NEWS15: Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019.NEWS16: Here's How Pfizer Gained 20.5% in 2018.NEWS17: Here's How Pfizer Gained 20.5% in 2018.NEWS18: First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch.NEWS19: First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch.NEWS20: 8 Dividend Stocks With Growth on the Horizon.NEWS21: 8 Dividend Stocks With Growth on the Horizon.NEWS22: Here&apos;s How Pfizer Gained 20.5% in 2018.
2019-01-16: NEWS1: Court rules against Pfizer in religious discrimination suit.NEWS2: Why Ligand Pharmaceuticals Tanked 25%.NEWS3: 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...).NEWS4: 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...).NEWS5: Is Pfizer a Buy?.NEWS6: Is Pfizer a Buy?.NEWS7: Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019.NEWS10: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019.NEWS11: Is Pfizer a Buy?.NEWS12: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS13: Fiserv to buy First Data in $22B all-stock deal.NEWS14: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS15: Pfizer (PFE) Gains But Lags Market: What You Should Know.
2019-01-17: NEWS1: The Stable Value Stock Is Built to Weather Market Storms.NEWS2: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.NEWS3: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.NEWS4: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS5: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.
2019-01-18: NEWS1: Top Stock Reports for Pfizer, Biogen & Schwab.NEWS2: Top Stock Reports for Pfizer, Biogen & Schwab.NEWS3: Top Stock Reports for Pfizer, Biogen & Schwab.NEWS4: Bulls bet on this biopharma company. Plus, the update on ....NEWS5: Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY.NEWS6: Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY.NEWS7: Baxter (BAX) Gains From Sharesource's Global Success Rates.NEWS8: Baxter (BAX) Gains From Sharesource's Global Success Rates.NEWS9: Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress.NEWS10: Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress.NEWS11: Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY.NEWS12: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS13: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS14: PFE's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'.NEWS15: PFE's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'.NEWS16: Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress.NEWS17: Baxter (BAX) Gains From Sharesource's Global Success Rates.

Answer: Decrease